Filana Therapeutics, Inc. Capital Expenditures
Filana Therapeutics, Inc. (FLNA) reported Capital Expenditures of $581.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-03-12
- Filana Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $501.00K, a 778.95% increase year-over-year.
- Filana Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $80.00K, a 370.59% increase year-over-year.
- Filana Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Filana Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $0.00.
- Filana Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $581.00K, a 464.08% increase from fiscal 2024.
- Filana Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $103.00K, a 75.12% decline from fiscal 2023.
- Filana Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $414.00K, a 84.73% decline from fiscal 2022.
- Filana Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $2.71M, a 87.79% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $501.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $581.00K derived: sum of 2 quarters · filed 2026-03-12 | $581.00K derived: sum of 3 quarters · filed 2026-03-12 | $581.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $80.00K derived: sum of 2 quarters · filed 2025-11-12 | $80.00K 10-Q · filed 2025-11-12 | $137.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $57.00K derived: sum of 3 quarters · filed 2026-03-12 | $74.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $57.00K derived: sum of 2 quarters · filed 2026-03-12 | $74.00K derived: sum of 3 quarters · filed 2026-03-12 | $103.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $74.00K derived: sum of 2 quarters · filed 2026-03-12 | $103.00K derived: sum of 3 quarters · filed 2026-03-12 | $103.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $46.00K derived: sum of 2 quarters · filed 2025-11-12 | $46.00K 10-Q · filed 2025-11-12 | $87.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $29.00K 10-Q · filed 2025-08-14 | $70.00K derived: sum of 3 quarters · filed 2026-03-12 | $92.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $41.00K derived: sum of 2 quarters · filed 2026-03-12 | $63.00K derived: sum of 3 quarters · filed 2026-03-12 | $57.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2023-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $63.00K derived: sum of 2 quarters · filed 2026-03-12 | $57.00K derived: sum of 3 quarters · filed 2026-03-12 | $414.00K 10-K · filed 2026-03-12 |
| 2023-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $16.00K derived: sum of 2 quarters · filed 2024-11-07 | $373.00K 10-Q · filed 2024-11-07 | $38.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $351.00K 10-Q · filed 2024-08-08 | $16.00K derived: sum of 3 quarters · filed 2025-03-03 | $1.17M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $357.00K 10-Q · filed 2024-05-10 | $22.00K derived: sum of 2 quarters · filed 2025-03-03 | $1.18M derived: sum of 3 quarters · filed 2025-03-03 | $2.64M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $821.00K derived: sum of 2 quarters · filed 2025-03-03 | $2.29M derived: sum of 3 quarters · filed 2025-03-03 | $2.71M 10-K · filed 2025-03-03 |
| 2022-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.62M derived: sum of 2 quarters · filed 2023-11-07 | $3.05M 10-Q · filed 2023-11-07 | $3.15M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.89M 10-Q · filed 2023-08-03 | $1.99M derived: sum of 3 quarters · filed 2024-02-28 | $24.03M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $425.00K 10-Q · filed 2023-05-01 | $525.00K derived: sum of 2 quarters · filed 2024-02-28 | $22.57M derived: sum of 3 quarters · filed 2024-02-28 | |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $22.14M derived: sum of 2 quarters · filed 2024-02-28 | $22.21M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $22.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $22.11M 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | $73.00K 10-Q · filed 2022-08-04 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $0.00 derived: sum of 2 quarters · filed 2021-03-23 | $0.00 derived: sum of 3 quarters · filed 2021-03-23 | $18.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $18.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $18.00K 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | $18.00K 10-Q · filed 2020-05-06 | |||
| 2016-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-06 | $75.00K 10-K · filed 2018-02-06 | ||
| 2016-09-30 | $76.00K 10-Q · filed 2017-11-01 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $0.00 derived: sum of 2 quarters · filed 2017-03-07 | $0.00 derived: sum of 3 quarters · filed 2017-03-07 | $195.00K 10-K · filed 2017-03-07 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | $0.00 derived: sum of 2 quarters · filed 2016-10-26 | $195.00K 10-Q · filed 2016-10-26 | $196.00K derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-19 | $195.00K 10-Q · filed 2016-07-19 | $196.00K derived: sum of 3 quarters · filed 2017-03-07 | $196.00K derived: sum of 4 quarters · filed 2017-03-07 |
| 2015-03-31 | $195.00K 10-Q · filed 2016-05-05 | $196.00K derived: sum of 2 quarters · filed 2017-03-07 | $196.00K derived: sum of 3 quarters · filed 2017-03-07 | $196.00K derived: sum of 4 quarters · filed 2017-03-07 |
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $1.00K derived: sum of 2 quarters · filed 2017-03-07 | $1.00K derived: sum of 3 quarters · filed 2017-03-07 | $80.00K 10-K · filed 2017-03-07 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $79.00K 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $79.00K 10-Q · filed 2015-07-23 | ||
| 2014-03-31 | $79.00K 10-Q · filed 2015-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |